drugset / Trial / NCT07319585

Managed Access Programs for EXV811, Atrasentan

NCT07319585 ↗

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to EXV811, Atrasentan

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Atrasentan Other / unclassified — —